Insiders · Profile

Encrantz Staffan

Director at Sight Sciences. Filing since 18 Oct 2021. CIK 0001870875

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jun 2026
Director
Bought
14,100
$68.79K
1.0%
16 Dec 2025
Director
Bought
13,958
$115.96K
1.0%
6 Jun 2025
Director
Bought
27,900
$117.74K
2.1%
5 Jun 2025
Director
Bought
40,951
$173.80K
3.2%
4 Jun 2025
Director
Bought
21,674
$90.42K
1.7%
3 Jun 2025
Director
Bought
25,230
$100.09K
2.0%
2 Jun 2025
Director
Bought
30,799
$119.44K
2.6%
30 May 2025
Director
Bought
42,753
$156.90K
3.7%
29 May 2025
Director
Bought
60,128
$215.74K
5.5%
28 May 2025
Director
Bought
26,715
$93.93K
2.5%
27 May 2025
Director
Bought
41,346
$142.06K
4.0%
21 Nov 2024
Director
Sold at will
551,802
$2.06M
46.6%
21 Nov 2024
Director
Bought
551,802
$2.06M
13.7%
30 Nov 2023
Director
Bought
140,777
$486.64K
16.2%
29 Nov 2023
Director
Bought
3,223
$11.28K
0.4%
28 Nov 2023
Director
Bought
253,669
$877.14K
41.3%
27 Nov 2023
Director
Bought
246,331
$815.95K
66.9%
24 Nov 2023
Director
Bought
21,855
$67.43K
6.3%
22 Nov 2023
Director
Bought
41,085
$102.71K
13.5%
21 Nov 2023
Director
Bought
68,477
$169.54K
28.9%
20 Nov 2023
Director
Bought
79,234
$178.19K
50.3%
17 Nov 2023
Director
Bought
126,664
$277.29K
411%
16 Nov 2023
Director
Bought
339
$678.00
1.1%
14 Nov 2023
Director
Bought
3,462
$6.91K
12.8%
17 May 2022
Director
Bought
250,000
$2.12M
82.8%
16 May 2022
Director
Bought
300,000
$2.46M
×166
13 May 2022
Director
Bought
1,802
$14.38K
opened
1 Dec 2021
Director
Bought
214,606
$4.81M
5.6%
30 Nov 2021
Director
Bought
223,940
$4.53M
6.2%
29 Nov 2021
Director
Bought
86,454
$1.63M
2.5%
18 Oct 2021
Director
Bought
527,048
$12.65M
17.7%
31 decisions on file.